POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE

Clinical trials for POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE explained in plain language.

Never miss a new study

Get alerted when new POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE trials appear

Sign up with your email to follow new studies for POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Completed 1

Two-Pronged attack on rare blood cancers shows promise in trial

Disease control Completed

This study tested whether combining two existing drugs, ruxolitinib and azacytidine, could better control certain rare blood cancers. It involved 121 adults with myelofibrosis or similar conditions where the bone marrow doesn't work properly. The goal was to see if using both dru…

Matched conditions: POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE

Get alerted when new POLYCYTHEMIA VERA, POST-POLYCYTHEMIC MYELOFIBROSIS PHASE trials appear

Two-Pronged attack on rare blood cancers shows promise in trial